Equity Research, Broker Reports, and media content on Oncimmune

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Oncimmune
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Oncimmune. We currently have 29 research reports from 5 professional analysts.

Open
N/A
Range Today
N/A
52 Week
79.0/132p
Daily Volume
N/A
# Shares
63.3m
Daily Liquidity
(0.03%)
Pension Liability
£0m
Enterprise Value
£66.3m
Market Cap
£56.9m
Latest PE (hist)
Div Yield
Date Source Announcement
20Sep19 14:32 RNS Appointment of Joint Broker
20Sep19 07:00 RNS EUR8.5m Credit Facility Secured
18Sep19 07:00 RNS-R Oncimmune to Present at 2019 CBIIC
09Sep19 07:30 RNS-R Positive Results for ECLS Trial Presentation
03Sep19 12:00 RNS-R ECLS at 2019 World Conference for Lung Cancer
01Aug19 12:00 RNS-R Solebury Trout European Biotech Investor Day
15Jul19 07:00 RNS-R Further Expansion in Spain for EarlyCDT Lung
  • Frequency of research reports

     

  • Research reports on

    Oncimmune

  • Providers covering

    Oncimmune